6-K ·Filed Jul 22, 2026

RDY

DR REDDYS LABORATORIES LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001575872-26-000514
Notable filing: 6-K
Actionable Insight • Neutral

No trading action warranted. This is a routine employee stock option grant with negligible dilution. Monitor next quarterly earnings for any changes to business fundamentals or guidance.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
RDY ▲ +6.41% at T+20d
NEUTRAL call ✓ call won +6.41% · α vs SPY +3.52% · entry $11.38 → $12.11
Next anchor: T+60d in 13d
Latest observation: T+49 +26.63% FF3 residual α
Entry anchored
Jul 21, 03:59 PM ET
via exchange tick
T+1d
+3.69%
call +3.69% · α +4.93%
$11.80
settled 2mo ago
T+5d
+3.34%
call +3.34% · α +5.74%
$11.76
settled 2mo ago
T+20d
+6.41%
call +6.41% · α +3.52%
$12.11
settled 6w ago
T+60d
—
call — · α —
—
in 13d

Price Chart

Loading chart...

Executive Summary

Dr. Reddy's Laboratories filed a routine 6-K on July 22, 2026, disclosing the grant of 15,933 stock options to an eligible employee under the company's existing ESOP scheme. The options have an exercise price of Rs. 1,206 per share and vest 100% after three years. This is a standard compensation action with no material financial impact or new strategic information.

Key Facts

  • Grant of 15,933 stock options to an eligible employee under the Dr. Reddy's Employees Stock Option Scheme, 2018.
  • Exercise price set at Rs. 1,206 per share (fair market value).
  • Options vest 100% at the end of 3 years.
  • Filing is a routine disclosure under SEBI regulations; no new business or financial information.

Financial Impact

Immaterial — 15,933 options represent less than 0.002% of total outstanding shares (834,656,970 as of last 20-F).

dilution

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
52% bullish (44 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001575872-26-000514
Document: 0001575872-26-000514-index.html0001575872-26-000514
Document: 0001575872-26-000514.txt0001575872-26-000514
51 reports for RDY
Performance horizon
67% Hit rate 6 of 9 directional calls best @ T+20▲ +23.28%Jun 26, 2026
Filters
Rows
Reports for RDY — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
6-K
NEUTRAL ★ 3/10
$11.91 $11.55▼ −3.02%▼ −2.56%$12.25 (+2.85%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 5/10
$11.71 $11.90▲ +1.62%▲ +0.77%$12.25 (+4.61%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 2/10
$11.71 $11.90▲ +1.62%▲ +0.77%$12.25 (+4.61%)
Aug 26, 2026
5w ago
6-K
NEUTRAL ★ 2/10
$12.22 $12.16▼ −0.49%▼ −1.15%$12.25 (+0.25%)
Aug 17, 2026
6w ago
6-K
MIXED ★ 5/10
$12.11 $12.15▲ +0.33%▲ +1.01%$12.25 (+1.16%)
Aug 13, 2026
7w ago
6-K
NEUTRAL ★ 3/10
$12.42 $12.27▼ −1.21%▼ −1.01%$12.25 (−1.37%)
Aug 10, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$12.15 $12.45▲ +2.47%▲ +2.79%$12.25 (+0.82%)
Aug 3, 2026
8w ago
6-K
BULLISH ★ 6/10
$12.07 $12.10▲ +0.25%▼ −1.55%$12.25 (+1.49%)
Jul 29, 2026
9w ago
6-K
NEUTRAL ★ 4/10
$11.76 $11.83▲ +0.60%▼ −1.08%$12.25 (+4.17%)
Jul 23, 2026
10w ago
6-K
NEUTRAL ★ 2/10
$11.80 $11.79▼ −0.08%▼ −0.19%$12.25 (+3.81%)
Showing 10 of 51

US Market Status

Market Closed — Opens Mon (65h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access